Hot Topics in Supportive Care in Cancer: New Evidence and Guidelines on Managing Dermatologic Toxicities and Drug Interactions Associated with Targeted Agents, and Treatment for Chemotherapy-Induced Emesis

Login required

Page 1 of 10: Frontmatter

10%

Target Audience
This activity is intended for medical and surgical oncologists, oncology nurses, advanced practice nurses, nurse practitioners, oncology pharmacists, and other healthcare professionals involved in treating patients with cancer.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Apply emerging concepts in understanding and managing dermatologic toxicities associated with targeted agents in oncology
  • Incorporate assessment and management protocols for cardiovascular adverse events in patients with cancer who are treated with targeted therapies
  • Utilize new indications and guidelines in treating chemotherapy-induced nausea and vomiting
  • Explain how to avoid drug–drug interactions with the newer targeted agents in oncology to avoid toxicity
Term of Offering
Release date: October 31, 2016
Expiration date: October 31, 2017

Estimated time to complete activity:1 hour
Faculty

Mario Lacouture, MD
Director of the Oncodermatology Program
Memorial Sloan Kettering Cancer Center
New York, NY

Richard Gralla, MD
Professor of Medicine (Oncology)
Albert Einstein College of Medicine
Bronx, NY

Sally Yowell Barbour, PharmD, BCOP, CPP
Director of Oncology Pharmacy Programs
Clinical Oncology Pharmacist
Duke University Medical Center
Durham, NC
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine and Center of Excellence Media, LLC, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Mario Lacouture, MD Consultant for AstraZeneca, Boehringer Ingelheim, Foamix, Genentech, Infinity Pharmaceuticals, Janssen R&D, Novartis, Quintiles, and RP Pharmaceuticals; principal investigator for Berg, Bristol-Myers Squibb, and Roche.
Richard Gralla, MD Consultant for Helsinn, Heron, Merck, and Tesaro, Inc.; speakers’ bureau for Heron and Merck.
Sally Yowell Barbour, PharmD, BCOP, CPP Nothing to disclose

The following PIM planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, RN, BSN; and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/ life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Center of Excellence Media, LLC: Susan Berry and Sy Schlager, MD, PhD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Physician Accreditation Statement
Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Center of Excellence Media, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Credit
There is no fee for this activity. To receive credit after reading this CME activity in its entirety, participants must complete the posttest and evaluation. The posttest and evaluation can be completed online at http://ce.lynxcme.com/COE406. Upon completion of the evaluation and scoring 75% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 75% or better on the posttest, you will be asked to take it again. Please retain a copy of the certificate for your records.

If you have any questions regarding the CE certification for this activity, please contact Postgraduate Institute for Medicine at: information@pimed.com or 303-799-1930.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
System Requirements
Windows 7 or higher or Mac OS X 10.6 or higher
Internet Explorer v9.0 or higher
Latest version of Google Chrome, Firefox, or Safari
Adobe Flash Player v10.0 or higher.
Adobe Acrobat Reader v7.0 or higher*

*Required to view printable (PDF) version of the lesson.
Provider Statement
This activity is supported by an independent educational grant from Tesaro, Inc.

This activity is jointly provided by Postgraduate Institute for Medicine and Center of Excellence Media. Center of Excellence Media

Login required